Effect of Peritumoral Infiltration of Local Anesthetic Before Surgery on Survival in Early Breast Cancer

Author:

Badwe Rajendra A.1ORCID,Parmar Vani1ORCID,Nair Nita1ORCID,Joshi Shalaka1ORCID,Hawaldar Rohini1ORCID,Pawar Suraj2,Kadayaprath Geeta3,Borthakur Bibhuti B.4ORCID,Rao Thammineedi Subramanyeshwar5ORCID,Pandya Shashank6,Balasubramanian Satheesan7ORCID,Chitale Priyadarshan V.8ORCID,Neve Rakesh9ORCID,Harris Caleb10,Srivastava Anurag11ORCID,Siddique Shabina1,Vanmali Vaibhav J.1,Dewade Ashwini1ORCID,Gaikwad Varsha1,Gupta Sudeep1ORCID

Affiliation:

1. Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India

2. Kolhapur Cancer Centre, Kolhapur, India

3. Max Superspeciality Hospital, Patparganj, New Delhi, India

4. B. Borooah Cancer Institute, Guwahati, India

5. Basavatarakam Indo-American Cancer Hospital and Research Centre, Hyderabad, India

6. Gujarat Cancer & Research Institute, Ahmedabad, India

7. Malabar Cancer Centre (MCC), Kodiyeri, Thalassery, Kannur, India

8. Siddhivinayak Ganapati Cancer Hospital, Miraj, India

9. Sterling Multi-Speciality Hospital, Pune, India

10. North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong, India

11. All India Institute of Medical Sciences, New Delhi, India

Abstract

PURPOSE Preventing metastases by using perioperative interventions has not been adequately explored. Local anesthesia blocks voltage-gated sodium channels and thereby prevents activation of prometastatic pathways. We conducted an open-label, multicenter randomized trial to test the impact of presurgical, peritumoral infiltration of local anesthesia on disease-free survival (DFS). METHODS Women with early breast cancer planned for upfront surgery without prior neoadjuvant treatment were randomly assigned to receive peritumoral injection of 0.5% lidocaine, 7-10 minutes before surgery (local anesthetics [LA] arm) or surgery without lidocaine (no LA arm). Random assignment was stratified by menopausal status, tumor size, and center. Participants received standard postoperative adjuvant treatment. Primary and secondary end points were DFS and overall survival (OS), respectively. RESULTS Excluding eligibility violations, 1,583 of 1,600 randomly assigned patients were included in this analysis (LA, 796; no LA, 804). At a median follow-up of 68 months, there were 255 DFS events (LA, 109; no LA, 146) and 189 deaths (LA, 79; no LA, 110). In LA and no LA arms, 5-year DFS rates were 86.6% and 82.6% (hazard ratio [HR], 0.74; 95% CI, 0.58 to 0.95; P = .017) and 5-year OS rates were 90.1% and 86.4%, respectively (HR, 0.71; 95% CI, 0.53 to 0.94; P = .019). The impact of LA was similar in subgroups defined by menopausal status, tumor size, nodal metastases, and hormone receptor and human epidermal growth factor receptor 2 status. Using competing risk analyses, in LA and no LA arms, 5-year cumulative incidence rates of locoregional recurrence were 3.4% and 4.5% (HR, 0.68; 95% CI, 0.41 to 1.11), and distant recurrence rates were 8.5% and 11.6%, respectively (HR, 0.73; 95% CI, 0.53 to 0.99). There were no adverse events because of lidocaine injection. CONCLUSION Peritumoral injection of lidocaine before breast cancer surgery significantly increases DFS and OS. Altering events at the time of surgery can prevent metastases in early breast cancer (CTRI/2014/11/005228). [Media: see text]

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3